Massimo Volpe (M Volpe)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 108

Top Venues

European heart journal

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Journal of human hypertension

Journal of clinical hypertension (Greenwich, Conn.)

Università degli Studi di Roma La Sapienza

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Roma La Sapienza Nov 1o 2001

Italy

Professore Ordinario di Cardiologia :: Medicina Clinica e Molecolare

Publications

Carla Letizia Busceti, Albino Carrizzo, Franca Bianchi, Massimiliano De Lucia, Antonio Damato, Chiara Cazzin, Eleonora Venturini, Paola Di Pietro, Roxana Paula Ginerete, Luisa Di Menna, Maria Cotugno, Rosita Stanzione, Simona Marchitti, Serena Migliarino, Michele Ciccarelli, Sebastiano Sciarretta, Valeria Bruno, Giuseppe Battaglia, Francesco Fornai, Massimo Volpe, Speranza Rubattu, Ferdinando Nicoletti, Carmine Vecchione
Role of Dickkopf-3 in Blood Pressure Regulation in Mice and Hypertensive Rats. Circulation research (2023)
Massimo Volpe, Carlo Patrono
The promise of selective aldosterone synthase inhibition for the management of resistant hypertension. European heart journal 44 (8) (2023)
Giovanna Gallo, Riccardo Sarzani, Arrigo Francesco Giuseppe Cicero, Stefano Genovese, Matteo Pirro, Luca Gallelli, Andrea Faggiano, Massimo Volpe
An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2023)
Daniela Pedicino, Massimo Volpe
Improving care for heart failure patients by COACHing clinicians to use decision-support tools. European heart journal (2023)
Daniela Pedicino, Massimo Volpe
Higher hospital readmissions in blacks after acute myocardial infarction: healthcare inequality gaps to fill in secondary prevention. European heart journal (2023)
Massimo Volpe, Armando Ferrera, Roberto Piccinocchi, Carmine Morisco
The Emerging Role of Prediabetes and Its Management: Focus on L-Arginine and a Survey in Clinical Practice. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2023)
Massimo Volpe, Carlo Patrono
Bempedoic acid: a CLEAR therapeutic option for statin-intolerant patients? European heart journal (2023)
Daniela Pedicino, Massimo Volpe
Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure: is it all gold the glitter in the CASTLE? European heart journal (2023)
Massimo Volpe, Allegra Battistoni
What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season? European heart journal supplements : journal of the European Society of Cardiology 25 (Suppl A) (2023)
Giovanna Liuzzo, Massimo Volpe
TRANSFORM-HF closes the loop on diuretic therapy in heart failure. European heart journal (2023)
Rocco Vergallo, Massimo Volpe
Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty? European heart journal (2023)
Rocco Vergallo, Massimo Volpe
Light the FIRE of revascularization in older patients with myocardial infarction. European heart journal (2023)
Giovanna Liuzzo, Massimo Volpe
24 Hour blood pressure monitoring is a better predictor of mortality than clinic blood pressure in a large cohort of primary care patients: what is the impact on clinical practice? European heart journal (2023)
Rocco Vergallo, Massimo Volpe
A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGE. European heart journal 44 (5) (2023)
Massimo Volpe, Giovanna Gallo, Speranza Rubattu
Endocrine functions of the heart: from bench to bedside. European heart journal 44 (8) (2023)
Daniela Pedicino, Massimo Volpe
Influenza vaccine for heart failure patients in low- and middle-income countries: another piece in the puzzle. European heart journal (2023)
Rocco Vergallo, Massimo Volpe
Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients. European heart journal (2023)
Daniela Pedicino, Massimo Volpe
Influenza vaccine for heart failure patients in low- and middle-income countries: another piece in the puzzle. European heart journal 44 (10) (2023)
Leonarda Galiuto, Massimo Volpe
Artificial intelligence in echocardiography: a better alternative to the human eye? European heart journal (2023)
Maria Lucia Narducci, Massimo Volpe
The revolution of beat-to-beat wireless bidirectional communication between intra-cardiac devices. European heart journal (2023)
Massimo Volpe, Leonarda Galiuto
More on aldosterone biosynthesis inhibition and resistant hypertension: a Phase-2 study with lorundrostat. European heart journal (2023)
Massimo Volpe, Giovanna Liuzzo
The 'cold case' of chlortalidone vs. hydrochlorothiazide in hypertension closed by the diuretic comparison project? European heart journal (2023)
Daniela Pedicino, Massimo Volpe
New evidence supporting haemodynamics-guided remote management of congestion in heart failure. European heart journal (2023)
Massimo Volpe, Allegra Battistoni
What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season? European heart journal supplements : journal of the European Society of Cardiology 25 (Suppl A) (2023)
Massimo Volpe, Daniela Pedicino
The promise of a new orally active body weight reducer. European heart journal (2023)
Daniela Pedicino, Massimo Volpe
Coffee drinking and cardiac ectopic beats: Black or White? European heart journal (2023)
Luis M Ruilope, Alberto Ortiz Arduan, Alejandro Lucia, Blanca Miranda, Gloria Alvarez-Llamas, Maria G Barderas, Massimo Volpe, Luis M Ruilope, Bertram Pitt
Prevention of cardiorenal damage: importance of albuminuria. European heart journal (2022)
Rocco Vergallo, Massimo Volpe
A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGE. European heart journal (2022)
Rocco Vergallo, Massimo Volpe
The DISCHARGE trial: imaging a new strategy for the clinical management of stable chest pain? European heart journal 43 (21) (2022)
Massimo Volpe, Leonarda Galiuto
Detection of risk factors in childhood: a new perspective in cardiovascular prevention. European heart journal 43 (24) (2022)
Rocco Vergallo, Massimo Volpe
Long lasting effects of renal denervation: lights and shadows of the SPYRAL HTN-ON MED 3-year follow-up. European heart journal 43 (28) (2022)
Giovanna Liuzzo, Massimo Volpe
PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction. European heart journal 43 (7) (2022)
Rocco Vergallo, Massimo Volpe
Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR. European heart journal (2022)
Massimo Volpe, Giovanna Gallo, Speranza Rubattu
Endocrine functions of the heart: from bench to bedside. European heart journal (2022)
Massimo Volpe, Carlo Patrono
One-shot thrombolysis for the management of acute ischaemic stroke. European heart journal 43 (38) (2022)
Massimo Volpe, Carlo Patrono
Blood pressure lowering drugs differ in their capacity to prevent type 2 diabetes. European heart journal 43 (12) (2022)
Leonarda Galiuto, Massimo Volpe
Treatment of mild hypertension improves pregnancy outcomes. European heart journal 43 (26) (2022)
Daniela Pedicino, Massimo Volpe
From the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide? European heart journal (2022)
Massimo Volpe, Carlo Patrono
Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management? European heart journal 42 (48) (2022)
Giovanna Gallo, Massimo Volpe, Speranza Rubattu
Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations. Vascular health and risk management 18 (2022)
Giovanna Liuzzo, Massimo Volpe
SARS-CoV-2 infection markedly increases long-term cardiovascular risk. European heart journal 43 (20) (2022)
Massimo Volpe, Carlo Patrono
Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges. European heart journal (2022)
Massimo Volpe, Daniela Pedicino
SGLT2 inhibitors DELIVER benefits in heart failure independently of ejection fraction and diabetes: end of the line or need for new studies? European heart journal 43 (44) (2022)
Massimo Volpe, Giovanna Liuzzo
VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan? European heart journal 43 (3) (2022)
Giovanna Liuzzo, Massimo Volpe
Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate. European heart journal 43 (15) (2022)
Giovanna Liuzzo, Massimo Volpe
Myocarditis after BNT162b2 mRNA SARS-CoV-2 vaccine: low incidence and mild severity. European heart journal (2022)
Massimo Volpe, Carlo Patrono
Age-independent benefits of blood pressure lowering: are they applicable to all patients? European heart journal 43 (6) (2022)
Daniela Pedicino, Massimo Volpe
Combination of ezetimibe and moderate-intensity statin for patients with atherosclerotic cardiovascular disease: a paradigm shift in lipid management landscape. European heart journal 43 (41) (2022)
Maria Lucia Narducci, Massimo Volpe
Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation. European heart journal 43 (34) (2022)
Rocco Vergallo, Massimo Volpe
Deciphering a decision support tool (CoDE-HF) to improve the diagnosis of acute heart failure. European heart journal 43 (33) (2022)
Daniela Pedicino, Massimo Volpe
Protection and delay of aortic complications in the Marfan syndrome: a new indication for angiotensin receptor blockers on top of β blockers. European heart journal (2022)
Rocco Vergallo, Massimo Volpe
The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis. European heart journal 43 (31) (2022)
Allegra Battistoni, Giuliano Tocci, Massimo Volpe
Diastolic Blood Pressure Levels and Cardiovascular Risk in Elderly Women: The Need for a Personalized Approach. American journal of hypertension 35 (9) (2022)
Massimo Volpe, Giovanna Gallo, Maria Grazia Modena, Claudio Ferri, Giovambattista Desideri, Giuliano Tocci, null null
Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 29 (2) (2022)
Massimo Volpe, Carlo Patrono
Drugs may worsen blood pressure control: focus on the underestimated role of non-steroidal anti-inflammatory drugs. European heart journal 43 (14) (2022)
Massimo Volpe, Carlo Patrono
The promise of selective aldosterone synthase inhibition for the management of resistant hypertension. European heart journal (2022)
Massimo Volpe, Giovanna Liuzzo
Unloading left heart with a shunt device shows no benefits in heart failure with preserved ejection fraction but supports the importance of phenotyping patients in clinical trials. European heart journal 43 (18) (2022)
Maria Lucia Narducci, Massimo Volpe
Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study. European heart journal 43 (4) (2022)
Massimo Volpe, Carlo Patrono
Vulnerable non-culprit coronary plaques: are they worth treating? European heart journal 42 (23) (2021)
Giovanna Gallo, Speranza Rubattu, Massimo Volpe
Targeting Cyclic Guanylate Monophosphate in Resistant Hypertension and Heart Failure: Are Sacubitril/Valsartan and Vericiguat Synergistic and Effective in Both Conditions? High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 28 (6) (2021)
Valérie Tikhonoff, Edoardo Casiglia, Paolo Spinella, Carlo M Barbagallo, Michele Bombelli, Arrigo F G Cicero, Massimo Cirillo, Pietro Cirillo, Giovambattista Desideri, Lanfranco D'elia, Claudio Ferri, Ferruccio Galletti, Loreto Gesualdo, Cristina Giannattasio, Guido Iaccarino, Francesca Mallamaci, Alessandro Maloberti, Stefano Masi, Alberto Mazza, Maria Lorenza Muiesan, Pietro Nazzaro, Paolo Palatini, Gianfranco Parati, Roberto Pontremoli, Fosca Quarti-Trevano, Marcello Rattazzi, Giulia Rivasi, Massimo Salvetti, Giuliano Tocci, Andrea Ungar, Paolo Verdecchia, Francesca Viazzi, Agostino Virdis, Massimo Volpe, Guido Grassi, Claudio Borghi, null null
Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study. Journal of human hypertension (2021)
Massimo Volpe, Carlo Patrono
The EMPEROR-Preserved study: end of the search for the "Phoenix" or beginning of a new season for trials in heart failure with preserved ejection fraction. European heart journal 42 (45) (2021)
Giovanna Liuzzo, Massimo Volpe
FIGARO-DKD adds new evidence to the cardiovascular benefits of finerenone across the spectrum of patients with type 2 diabetes and chronic kidney disease. European heart journal 42 (47) (2021)
Massimo Volpe, Giovanna Gallo
Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike? European heart journal 42 (36) (2021)
Massimo Volpe, Carlo Patrono
Worsening of risk factor control in US diabetic patients: a call to action. European heart journal 42 (33) (2021)
Massimo Volpe, Carlo Patrono
A SPRINT towards tighter control of blood pressure in hypertension. European heart journal 42 (32) (2021)
Allegra Battistoni, Massimo Volpe
Repurposing Cardio-Metabolic Drugs to Fight Covid19. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 28 (5) (2021)
Massimo Volpe, Carlo Patrono
Another STEP towards tighter control of blood pressure in the elderly. European heart journal 42 (46) (2021)
Massimo Volpe, Giovanna Gallo, Speranza Rubattu
Novel ANP (Atrial Natriuretic Peptide)-Based Therapy for Hypertension: The Promising Role of a Disease Mechanism Targeted Approach. Hypertension (Dallas, Tex. : 1979) 78 (6) (2021)
Vivianne Presta, Ilaria Figliuzzi, Barbara Citoni, Giovanna Gallo, Allegra Battistoni, Giuliano Tocci, Massimo Volpe
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 28 (3) (2021)
Giovanna Liuzzo, Massimo Volpe
An inflammatory ageing clock to detect cardiovascular and other age-related diseases: a new approach to preventive medicine. European heart journal 42 (42) (2021)
Costantino Mancusi, Guido Grassi, Claudio Borghi, Claudio Ferri, Maria Lorenza Muiesan, Massimo Volpe, Guido Iaccarino, null null
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 28 (1) (2021)
Massimo Volpe, Carlo Patrono
The cardiovascular benefits of statins outweigh adverse effects in primary prevention: results of a large systematic review and meta-analysis. European heart journal 42 (44) (2021)
Barbara Citoni, Ilaria Figliuzzi, Vivianne Presta, Vincenzo Cesario, Francesca Miceli, Franca Bianchi, Andrea Ferrucci, Massimo Volpe, Giuliano Tocci
Prevalence and clinical characteristics of isolated systolic hypertension in young: analysis of 24 h ambulatory blood pressure monitoring database. Journal of human hypertension (2021)
Barbara Citoni, Ilaria Figliuzzi, Vivianne Presta, Massimo Volpe, Giuliano Tocci
Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2021)
Leonarda Galiuto, Massimo Volpe
Glycaemicindex: an emergent global silent killer for the heart. European heart journal 42 (28) (2021)
Massimo Volpe, Carlo Patrono
The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile. European heart journal 42 (29) (2021)
Maurizio Forte, Franca Bianchi, Maria Cotugno, Simona Marchitti, Rosita Stanzione, Vittorio Maglione, Sebastiano Sciarretta, Valentina Valenti, Roberto Carnevale, Francesco Versaci, Giacomo Frati, Massimo Volpe, Speranza Rubattu
An interplay between UCP2 and ROS protects cells from high-salt-induced injury through autophagy stimulation. Cell death & disease 12 (10) (2021)
Massimo Volpe, Carlo Patrono
The increased mortality of STEMI patients without risk factors supports the need for evidence-based pharmacotherapy irrespective of perceived low risk. European heart journal 42 (24) (2021)
Massimo Volpe, Giovanna Gallo
Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists. Cardiovascular research 117 (9) (2021)
Giovanna Liuzzo, Massimo Volpe
Unhealthy lifestyles mediate only a small proportion of the socioeconomic inequalities' impact on cardiovascular outcomes in US and UK adults: a call for action for social cardiology. European heart journal 42 (25) (2021)
Francesco Paneni, Massimo Volpe
Exploring RNA biomarkers in patients with acute myocarditis. European heart journal 42 (35) (2021)
Giuliano Tocci, Maria Lorenza Muiesan, Massimo Volpe
Hypertension Management and Control in Italy: A Real-World Survey in Elderly Patients. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 28 (5) (2021)
Alessandro Biffi, Giovanna Gallo, Fredrick Fernando, Felice Sirico, Maria Grazia Signorello, Michele Messina, Giorge Manole, Nicola Triglione, Massimo Volpe
Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company. Journal of human hypertension (2021)
Vincenzo Cesario, Vivianne Presta, Ilaria Figliuzzi, Barbara Citoni, Allegra Battistoni, Francesca Miceli, Massimo Volpe, Giuliano Tocci
Epidemiological Impact and Clinical Consequences of Masked Hypertension: A Narrative Review. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 27 (3) (2020)
Guido Iaccarino, Claudio Borghi, Arrigo Francesco Giuseppe Cicero, Claudio Ferri, Pietro Minuz, Maria Lorenza Muiesan, Paolo Mulatero, Giuseppe Mulè, Giacomo Pucci, Massimo Salvetti, Carmine Savoia, Leonardo Alberto Sechi, Massimo Volpe, Guido Grassi
Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 27 (2) (2020)
Giuliano Tocci, Vivianne Presta, Claudio Ferri, Josep Redon, Massimo Volpe
Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 27 (1) (2020)
Francesca Miceli, Vivianne Presta, Barbara Citoni, Flaminia Canichella, Ilaria Figliuzzi, Andrea Ferrucci, Massimo Volpe, Giuliano Tocci
Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review. Journal of clinical hypertension (Greenwich, Conn.) 21 (12) (2019)
Massimo Volpe, Giovanna Gallo, Allegra Battistoni, Giuliano Tocci
Highlights of ESC/ESH 2018 Guidelines on the Management of Hypertension: What Every Doctor Should Know. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 26 (1) (2019)
Giuliano Tocci, Barbara Citoni, Vivianne Presta, Giovanna Leoncini, Francesca Viazzi, Barbara Bonino, Massimo Volpe, Roberto Pontremoli
Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits. Internal and emergency medicine 15 (3) (2019)
Stefano Omboni, Massimo Volpe
Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan. Advances in therapy 36 (2) (2018)
Ilaria Figliuzzi, Vivianne Presta, Francesca Miceli, Barbara Citoni, Roberta Coluccia, Giovanni Ceccarini, Guido Salvetti, Ferruccio Santini, Maria Beatrice Musumeci, Andrea Ferrucci, Massimo Volpe, Giuliano Tocci
24-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity. Journal of human hypertension 33 (4) (2018)
Massimo Volpe, Allegra Battistoni, Giovanna Gallo, Speranza Rubattu, Giuliano Tocci, null null, null null
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 25 (3) (2018)
Niki Katsiki, Konstantinos P Tsioufis, Dilek Ural, Massimo Volpe
Fifteen years of LIFE (Losartan Intervention for Endpoint Reduction in Hypertension)-Lessons learned for losartan: An "old dog playing good tricks". Journal of clinical hypertension (Greenwich, Conn.) (2018)
Stefano Omboni, Massimo Volpe
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan. Cardiovascular therapeutics 36 (6) (2018)
Vivianne Presta, Ilaria Figliuzzi, Barbara Citoni, Francesca Miceli, Allegra Battistoni, Maria Beatrice Musumeci, Roberta Coluccia, Luciano De Biase, Andrea Ferrucci, Massimo Volpe, Giuliano Tocci
Effects of different statin types and dosages on systolic/diastolic blood pressure: Retrospective analysis of 24-hour ambulatory blood pressure database. Journal of clinical hypertension (Greenwich, Conn.) 20 (5) (2018)
Massimo Volpe, Vivianne Presta
Inflammatory residual risk: An emerging target to reduce cardiovascular disease? Clinical cardiology 41 (4) (2018)
Massimo Volpe, Allegra Battistoni, Giovanna Gallo, Roberta Coluccia, Raffaele De Caterina
Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 24 (3) (2017)
Roberto Carnevale, Pasquale Pignatelli, Giacomo Frati, Cristina Nocella, Rosita Stanzione, Daniele Pastori, Simona Marchitti, Valentina Valenti, Maria Santulli, Emanuele Barbato, Teresa Strisciuglio, Leonardo Schirone, Carmine Vecchione, Francesco Violi, Massimo Volpe, Speranza Rubattu, Sebastiano Sciarretta
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP. Scientific reports 7 (1) (2017)
Massimo Volpe
Calcium Channel Blockers for the Clinical Management of Hypertension. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 25 (1) (2017)

Massimo Volpe.css-eqlu8i{font-size:small;padding-left:4px;} (M Volpe)

Publication Activity (10 Years)

Top Topics

Top Venues

Massimo Volpe (M Volpe)